Publications by authors named "Patrick Yeni"

Claim this Profile
[
[ F]FDG Positron Emission Tomography for Initial Staging and Healing Assessment at the End of Therapy in Lymph Nodes and Bone Tuberculosis.
Laure Sarda-Mantel, Jidar Kaoutar, Toni Alfaiate, Amanda Lopes, Frédéric Paycha

Front Med (Lausanne)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic syndrome and endocrine status in HIV-infected transwomen.
Jean-David Pommier, Cedric Laouénan, Florence Michard, Emmanuelle Papot, Paul Urios, Patrick Yeni

AIDS· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL).
Véronique Joly, Charles Burdet, Roland Landman, Marie Vigan, Charlotte Charpentier, Patrick Yeni

J Antimicrob Chemother· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessement of Awareness of, Concerns and Attitudes Towards HIV-Related Court-Case Sentences in France in a Representative Sample of People Living with HIV (ANRS VESPA2 Survey).
Marie Suzan-Monti, Michel Celse, Antoine Vilotitch, Baptiste Demoulin, Rosemary Dray-Spira

AIDS Behav· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget impact of antiretroviral therapy in a French clinic cohort.
Emmanuelle Papot, Roland Landman, Françoise Louni, Charlotte Charpentier, Gilles Peytavin, Patrick Yeni

AIDS· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study.
Vincent Madelain, Minh P Le, Karen Champenois, Charlotte Charpentier, Roland Landman, Patrick Yeni

J Antimicrob Chemother· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiological Profile of Newly Diagnosed HIV-Infected Patients in Northern Paris: A Retrospective Study.
Olivia Senard, Charles Burdet, Benoit Visseaux, Charlotte Charpentier, Sylvie Le Gac, Patrick Yeni

AIDS Res Hum Retroviruses· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abacavir has no prothrombotic effect on platelets in vitro.
Yacouba L Diallo, Véronique Ollivier, Véronique Joly, Dorothée Faille, Giovanna Catalano, Patrick Yeni

J Antimicrob Chemother· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir/Emtricitabine/Rilpivirine: A W96 Follow-Up.
Charlotte Charpentier, Minh Patrick Lê, Véronique Joly, Benoit Visseaux, Sylvie Lariven

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between first-year virological response to raltegravir and long-term outcomes in treatment-experienced patients with HIV-1 infection.
Joseph J Eron, David A Cooper, Roy T Steigbigel, Bonaventura Clotet, Patrick Yeni

Antivir Ther· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial).
Lionel Piroth, Laetitia Moinot, Patrick Yeni, Véronique Avettand-Fénoel, Jacques Reynes

J Antimicrob Chemother· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes After a Switch to a Single-Tablet Regimen of Rilpivirine, Emtricitabine, and Tenofovir DF in HIV-1-Positive, Virologically Suppressed Individuals: Additional Findings From a Randomized, Open-Label, 48-Week Trial.
Jason Brunetta, Santiago Moreno Guillén, Andrea Antinori, Patrick Yeni, Barbara Wade

Patient· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial.
Antoine Chéret, Georges Nembot, Adeline Mélard, Caroline Lascoux, Laurence Slama, Patrick Yeni

Lancet Infect Dis· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART.
Petra El Khoury, Mathilde Ghislain, Elise F Villard, Wilfried Le Goff, Caroline Lascoux-Combe, Patrick Yeni

J Lipid Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO).
David A Wohl, Chloe Orkin, Manuela Doroana, José H Pilotto, Somnuek Sungkanuparph, Patrick Yeni

Antivir Ther· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assay.
Charlotte Charpentier, Marion Choquet, Véronique Joly, Patrick Yeni, Benoit Visseaux

J Antimicrob Chemother· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[HIV infection. Screening, broadcast treatment and prevention of infection are now linked ].
Patrick Yeni

Rev Prat· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[HIV infection and social condition: a disease which remains singular].
Michel Celse, Laurent Geffroy, Patrick Yeni

Rev Prat· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change in HIV-1 DNA tropism despite virological success in patients receiving an enfuvirtide-based regimen.
Charlotte Charpentier, Véronique Joly, Jade Ghosn, Patrick Yeni, François Raffi

J Antimicrob Chemother· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skeletal muscle toxicity associated with emtricitabine/rilpivirine/tenofovir fixed-dose combination: a case report.
Liem Binh Luong Nguyen, Stanislas Harent, Gilles Peytavin, Benoit Visseaux, Jean P Bastard, Patrick Yeni

AIDS· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts.
Evguenia Krastinova, Remonie Seng, Patrick Yeni, Jean-Paul Viard, Daniel Vittecoq

PLoS One· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.
Joseph J Eron, David A Cooper, Roy T Steigbigel, Bonaventura Clotet, Jose M Gatell, Patrick Yeni

Lancet Infect Dis· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiretroviral treatments in 2012: improvements and future prospects.
Charlotte Charpentier, Véronique Joly, Patrick Yeni, Françoise Brun-Vézinet

Virologie (Montrouge)· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial.
Charlotte Charpentier, Véronique Joly, Lucile Larrouy, Catherine Fagard, Benoit Visseaux, Patrick Yeni

J Antimicrob Chemother· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensification of antiretroviral therapy through addition of enfuvirtide in naive HIV-1-infected patients with severe immunosuppression does not improve immunological response: results of a randomized multicenter trial (ANRS 130 Apollo).
Véronique Joly, Catherine Fagard, Carine Grondin, Diane Descamps, Yazdan Yazdanpanah, Patrick Yeni

Antimicrob Agents Chemother· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis